Sight Sciences, Inc. (SGHT)

USD 3.41

(-5.8%)

Market Cap (In USD)

173.07 Million

Revenue (In USD)

81.05 Million

Net Income (In USD)

-55.54 Million

Avg. Volume

215.69 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.12-8.45
PE
-
EPS
-
Beta Value
2.734
ISIN
US82657M1053
CUSIP
82657M105
CIK
1531177
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Paul Badawi
Employee Count
-
Website
https://www.sightsciences.com
Ipo Date
2021-07-15
Details
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.